Try our Advanced Search for more refined results

Royalty Pharma Revises Conditions Of $6B Elan Takeover

By Jake Simpson (May 23, 2013, 1:27 PM EDT) -- Royalty Pharma AG said Thursday that it would lower the threshold for shareholder acceptance of its $6.3 billion hostile takeover bid for U.K. drugmaker Elan Corp. from 90 to 50 percent plus one share, while Elan rejected the New York investor's latest offer....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!